Ajai Chari Selected Research

Ajai Chari Research Topics

Disease

120	Multiple Myeloma 04/2024 - 09/2010
20	Neoplasms (Cancer) 04/2024 - 01/2013
6	Infections 01/2024 - 01/2017
4	Agammaglobulinemia (Hypogammaglobulinemia) 11/2023 - 01/2020
4	Disease Progression 11/2021 - 05/2015
3	Fatigue 12/2021 - 04/2016
3	COVID-19 01/2021 - 06/2020
3	Smoldering Multiple Myeloma 01/2021 - 01/2018
3	Hypertension (High Blood Pressure) 11/2020 - 10/2018
3	Neutropenia 01/2020 - 01/2017
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 07/2010
2	Chromosome Aberrations (Chromosome Abnormalities) 04/2024 - 01/2013
2	Body Weight (Weight, Body) 12/2022 - 11/2022
2	Thrombocytopenia (Thrombopenia) 12/2021 - 01/2020
2	Nausea 12/2021 - 01/2020
2	Lymphoma (Lymphomas) 01/2016 - 12/2009
2	Plasma Cell Neoplasms 10/2013 - 10/2012
1	Thrombosis (Thrombus) 11/2022
1	Cytokine Release Syndrome 09/2021
1	Cytopenia 09/2021
1	Bone Diseases (Bone Disease) 12/2020
1	Melanoma (Melanoma, Malignant) 02/2020
1	Hyponatremia 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Diarrhea 01/2020
1	Vomiting 01/2020

Drug/Important Bio-Agent (IBA)

32	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 11/2016
31	daratumumabIBA 04/2024 - 01/2016
19	Lenalidomide (CC 5013)FDA Link 04/2024 - 01/2016
18	Bortezomib (Velcade)FDA Link 04/2024 - 09/2010
17	Proteasome InhibitorsIBA 11/2023 - 09/2010
16	selinexorIBA 05/2023 - 01/2018
14	Monoclonal AntibodiesIBA 11/2023 - 04/2016
14	carfilzomibIBA 05/2023 - 12/2014
8	Immunomodulating AgentsIBA 11/2021 - 04/2016
7	B-Cell Maturation AntigenIBA 03/2024 - 01/2020
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2016
6	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 03/2024 - 01/2020
6	Bispecific AntibodiesIBA 01/2024 - 09/2021
5	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 10/2012
5	ixazomibIBA 12/2022 - 09/2016
4	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2023
3	belantamab mafodotinIBA 12/2023 - 01/2020
3	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2020
3	PanobinostatIBA 11/2021 - 09/2018
3	Exportin 1 ProteinIBA 01/2021 - 01/2018
3	Melphalan (Alkeran)FDA LinkGeneric 11/2020 - 03/2016
3	AntigensIBA 02/2020 - 01/2017
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2023 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2019
2	filanesibIBA 01/2022 - 11/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2020
2	KinesinsIBA 01/2022 - 11/2016
2	Immunoglobulin G (IgG)IBA 11/2020 - 06/2020
2	ibrutinibIBA 08/2020 - 11/2018
2	fibrin fragment D (D-dimer)IBA 06/2020 - 01/2020
2	Ferritins (Ferritin)IBA 06/2020 - 01/2020
2	pomalidomideIBA 01/2020 - 01/2017
2	ParaproteinsIBA 10/2013 - 12/2009
1	Adenosine Monophosphate (AMP)IBA 04/2024
1	elotuzumabIBA 04/2024
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2024
1	Surface Antigens (Surface Antigen)IBA 01/2024
1	Fc Receptors (Fc Receptor)IBA 01/2024
1	vinyltriethoxysilane (VTES)IBA 11/2022
1	InterferonsIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	7- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA 12/2021
1	Histone Deacetylase InhibitorsIBA 11/2021
1	SteroidsIBA 10/2021
1	Immunologic Factors (Immunomodulators)IBA 09/2021
1	isatuximabIBA 01/2021
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	bismuth subsalicylate (Pepto-bismol)FDA LinkGeneric 01/2020
1	Serotonin 5-HT3 Receptor AntagonistsIBA 01/2020
1	Loperamide (Imodium)FDA LinkGeneric 01/2020
1	MegestrolIBA 01/2020
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2020
1	Neurokinin-1 Receptor AntagonistsIBA 01/2020
1	Protein Subunit VaccinesIBA 01/2020
1	CannabinoidsIBA 01/2020
1	VaccinesIBA 01/2020

Therapy/Procedure

55	Therapeutics 04/2024 - 01/2013
7	Stem Cell Transplantation 04/2024 - 09/2015
4	Immunotherapy 01/2024 - 01/2016
4	Transplantation 10/2023 - 07/2010
2	Salvage Therapy 03/2024 - 01/2023
2	Duration of Therapy 11/2023 - 01/2018
2	Aftercare (After-Treatment) 01/2023 - 10/2013
2	Hematopoietic Stem Cell Mobilization 01/2023 - 07/2010
2	Drug Therapy (Chemotherapy) 01/2022 - 06/2015
2	Artificial Respiration (Mechanical Ventilation) 11/2020 - 06/2020
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2020 - 01/2018
1	Retreatment 03/2024
1	Subcutaneous Injections 11/2022
1	Radiotherapy 01/2022
1	Intravenous Infusions 01/2020